Characterization of Heat-Labile toxin-subunit B from Escherichia coli by liquid chromatography-electrospray ionization-mass spectrometry and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

Food and Chemical Toxicology

Volumn 50, Issue 11, 2012, Pages 3886-3891

  Sospedra, I ^a   De Simone, C ^b   Soriano, J M ^a   Manes J ^a   Ferranti, P ^b   Ritieni, A ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

B subunit; Escherichia coli; Heat labile toxin; Mass spectrometry

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI PROTEIN; LABILE TOXIN SUBUNIT B; UNCLASSIFIED DRUG;

ACCURACY; ALKYLATION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL MEMBRANE; BETA CHAIN; CONTROLLED STUDY; DISULFIDE BOND; ELECTROSPRAY MASS SPECTROMETRY; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PREDICTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TOXIN ANALYSIS; TOXIN STRUCTURE;

AMINO ACID SEQUENCE; BACTERIAL TOXINS; CHROMATOGRAPHY, LIQUID; DISULFIDES; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PHOSPHORYLATION; PICHIA; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRYPSIN;

ESCHERICHIA COLI; PICHIA PASTORIS;

EID: 84866010630     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.08.014     Document Type: Article

References (39)

1. Amin, T., T.R. Hirst., 1994. Purification of the B-subunit oligomer of Escherichia coli heat-labile enterotoxin by heterologous expression and secretion in a marine vibrio. Protein Expr. Purif. 5, 198-204.
2. Aranda-Michel J., Gianella R.A. Acute diarrhea: a practical review. Am. J. Med. 1999, 106:670-676.
3. Bagdasarian M.M., Nagai M., Frey J., Bagdasarian M. Immunogenicity of Actinobacillus ApxIA toxin epitopes fused to the E. coli heat-labile enterotoxin B subunit. Vaccine 1999, 17:441-447.
4. Chan S.K., Giannella R.A. Amino acid sequence of heat-stable enterotoxin produced by Escherichia coli pathogenic for man. J. Biol. Chem. 1981, 256:7744-7746.
5. Clements J.D., Yancey R.J., Finkelstein R.A. Properties of homogeneous heat-labile enterotoxin from Escherichia coli. Infect. Immun. 1980, 24:91-97.
6. Coster T.S., Wolf M.K., Hall E.R., Cassels F.J., Taylor D.N., Liu C.T., Trespalacios F.C., DeLorimier A., Angleberger D.R., McQueen C.E. Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infect. Immun. 2007, 75:252-259.
7. Dallas W.S., Falkow S. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature 1980, 288:499-501.
8. Dickinson, B.L., Clements, J.D., 1996. Escherichia coli heatlabile enterotoxin as an oral adjuvant, in: Kiyono, H., Ogra, P.L., McGhee, J.R. (Eds.), Mucosal vaccines. Academic Press, Inc., San Diego, Calif., pp. 73-87.
9. Evans D.J., Chen L.C., Curlin G.T., Evans D.G. Stimulation of adenyl cyclase by Escherichia coli enterotoxin. Nature New Biol. 1972, 236:137-138.
10. Feng, P., Weagant, S., Grant, M., 2002. "Enumeration of Escherichia coli and the Coliform Bacteria" Bacteriological Analytical Manual (8th ed.). FDA/Center for Food Safety & Applied Nutrition.
11. Godovac-Zimmermann J., Brown L.R. Perspectives for mass spectrometry and functional proteomics. Mass Spectrom. Rev. 2001, 20:1-57.
12. Handl C.E., Flock J.A. STb producing Escherichia coli are rarely associated with infantile diarrhoea. J. Diarrhoeal Dis. Res. 1992, 10:37-38.
13. Hart, G.W., Akimoto, Y., in: Essentials of Glycobiology. Varki, A., Cummings, R. D., Esko, J. D., et al., (Eds.) Cold Spring Harbor Laboratory Press, N.Y., 2009, chapter 18.
14. Holmgren J., Svennerholm A.M. Bacterial enteric infections and vaccine development. Gastroenterol. Clin. North. Am. 1992, 21:283-302.
15. Jacks T.M., Wu B.J., Braemer A.C., Bidlack D.E. Properties of the Enterotoxic Component in Escherichia coli Enteropathogenic for Swine. Infect. Immun. 1973, 7:178-189.
16. Kim T.G., Kim M.Y., Kim B.G., Kang T.J., Kim Y.S., Jang Y.S., Arntzen C.J., Yang M.S. Synthesis and assembly of Escherichia coli heat-labile enterotoxin B subunit in transgenic lettuce (Lactuca sativa). Protein Expr. Purif. 2007, 51:22-27.
17. Ma X., Yao B., Zheng W., Li L. Comparative Study on Characterization of Recombinant B Subunit of E. coli Heat-Labile Enterotoxin (rLTB) Prepared from E. coli and P. pastoris. J. Microbiol. Biotechnol. 2010, 20:550-557.
18. M1 binding. Toxins 2010, 2:1445-1470.
19. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 1998, 11:142-201.
20. Park J.W., Mieyal J.J., Rhee S.G., Chock P.B. Deglutathionylation of 2-Cys Peroxiredoxin is Specifically Catalyzed by Sulfiredoxin. J. Biol. Chem. 2009, 284:23364-23374.
21. Pizza M., Giuliani M.M., Fontana M.R., Monaci E., Douce G., Dougan G., Mills K.H., Rappuoli R., Del Giudice G. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 2001, 19:2534-2541.
22. Ranallo R.T.Piyumi., Fonseka C., Cassels F., Srinivasan J., Venkatesan M.M. Construction and Characterization of Bivalent Shigella flexneri 2a Vaccine Strains SC608(pCFAI) and SC608(pCFAI/LTB) That Express Antigens from Enterotoxigenic Escherichia coli. Infect. Immun. 2005, 73:258-267.
23. Selzer J., Hofmann F., Rex G., Wilm M., Mann M., Just I., Aktories K. Clostridium novyi α-Toxin-catalyzed Incorporation of GlcNAc into Rho Subfamily Proteins J. Biol. Chem. 1996, 271:25173-25177.
24. Shafi R., Iyer S.P., Ellies L.G., O'Donnell N., Marek K.W., Chui D., Hart G.W., Marth J.D. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:5735-5739.
25. Sharp G.W.G., Hynie S., Ebel H., Parkinson D.K., Witkum P. Properties of adenylate cyclase in mucosal cells of the rabbit ileum and the effect of cholera toxin. Biochim. Biophys. Acta 1973, 309:339-348.
26. Sheen S., Hwang C.A. Mathematical modeling the cross-contamination of Escherichia coli O157:H7 on the surface of ready-to-eat meat product while slicing. Food Microbiol. 2010, 27:37-43.
27. Spangler B.D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 1992, 56:622-647.
28. Spicer E.K., Noble J.A. Escherichia coli heat-labile enterotoxin. Nucleotide sequence of the A subunit gene. J. Biol. Chem. 1982, 257:5716-5721.
29. Tacket C.O., Mason H.S., Losonsky G., Clements J.D., Levine M.M., Arntzen C.J. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 1998, 4:607-609.
30. Takao T., Hitouji T., Aimoto S., Shimonishi Y., Hara S., Takeda T., Takeda Y., Miwatani T. Amino acid sequence of a heat-stable enterotoxin isolated from enterotoxigenic Escherichia coli strain 18D. FEBS Lett. 1983, 152:l-5.
31. Tsuji T., Taga S., Honda T., Takeda Y., Miwatani T. Molecular heterogeneity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli. Infect. Immun. 1982, 38:444-448.
32. Van Baar B.L.M., Hulst A.G., Wils E.R.J. Characterisation of cholera toxin by liquid chromatography-electrospray mass spectrometry. Toxicon 1999, 37:85-108.
33. Vicente A.C., Teixeira L.F., Iniguez-Rojas L., Luna M.G., Silva L., Andrade J.R., Guth B.E. Outbreaks of cholera-like diarrhoea caused by enterotoxigenic Escherichia coli in the Brazilian Amazon Rainforest. Trans. R. Soc. Trop. Med. Hyg. 2005, 99:669-674.
34. Vinal A.C., Dallas W.S. Partition of heat-labile-enterotoxin genes between human and animal Escherichia coli isolates. Infect. Immun. 1987, 55:1329-1331.
35. Vogt R.L., Dippold L. Escherichia coli O157:H7 outbreak associated with consumption of ground beef, June-July 2002. Public Health Rep. 2005, 120:174-178.
36. Williams N.A., Hirst T.R., Nashar T.O. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol. Today 1999, 20:95-101.
37. World Health Organization, (WHO) 2005. http://www.who.int/vaccine research/ about/gvrf/Qadri.pdf.
38. Yamamoto T., Yokota T. Sequence of heat-labile enterotoxin of Escherichia coli pathogenic for humans. J. Bacteriol. 1983, 155:728-733.
39. Yu J., Langridge W.H. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. Biotechnol. 2001, 19:548-552.